Midterm outcome of endovascular repair of ruptured abdominal aortic aneurysms  by Hechelhammer, Lukas et al.
Midterm outcome of endovascular repair of
ruptured abdominal aortic aneurysms
Lukas Hechelhammer, MD,a Mario L. Lachat, MD,b Simon Wildermuth, MD,a Dominique Bettex, MD,c
Dieter Mayer, MD,b and Thomas Pfammatter, MD,a Zurich, Switzerland
Purpose:We sought to analyze the clinical and morphologic outcomes of bifurcated stent grafts in patients with ruptured
aortoiliac aneurysms at midterm follow-up.
Methods: Thirty-seven patients (4 women; mean age, 73 years; mean abdominal aortic aneurysm [AAA] diameter, 77 mm)
underwent endovascular abdominal aneurysm repair between June 1997 and July 2003 for ruptured AAA. Devices
inserted were as follows: Vanguard (Boston Scientific, Natick, Mass; n  7), Excluder (W.L. Gore, Flagstaff, Ariz; n 
25), Talent (Medtronic Vascular, Santa Rosa, Calif; n 2), and Zenith (Cook Inc, Bloomington, Ind; n 3). Except for
the adjunct postimplantation computed tomographic scanning, the imaging follow-up was the same as for nonruptured
AAAs.
Results:Themean follow-up periodwas 24months (range, 1-59)months. Thirty-daymortality was 10.8%. Three patients
died during the follow-up of non-AAA–related causes. One patient was converted early for presumed renal overstenting.
The late conversion rate was 9% because of stent graft migration (n 2) or infection (n 1). Freedom from endoleak was
57% 8.5% and 48.8% 9% at 2 and 4 years, respectively. Seventeen secondary interventions were performed during the
follow-up period, 41% of these within 1 month of stent graft placement. Endoleaks, primary or secondary, were
responsible for 58.8% of these interventions. The cumulative risk of a secondary intervention was 35.3%  9% at 2 years
and 44.6%  11% at 3 years. Aneurysmal sac shrinkage was observed in 30.8%  9.1% and sac enlargement was observed
in 15.3%  10.8% at 2 years.
Conclusion: Endoluminal devices are able to convert the acute life-threatening situation of ruptured AAA to a controlled
situation that results in good patient survival at midterm follow-up. (J Vasc Surg 2005;41:752-7.)The most feared complication of an abdominal aortic
aneurysm (AAA) is rupture, which is responsible for 35% to
63% of deaths in untreated patients within 5 years after
diagnosis.1 Standard treatment of a ruptured AAA (rAAA)
consists of laparatomy and repair with an aortic graft during
general anesthesia. Since the first surgical treatment of a
rAAA in 1951,2 operative mortality rates have been gradu-
ally reduced by 3.5% per decade but are still high, with an
estimated value of 41% for the year 2000.3 This can be
explained in part by the fact that although progress has
been achieved in patient transportation and intensive care,
the surgical techniques used in the treatment of rAAA have
not basically changed.
Transluminal stent grafting has rapidly evolved as an
alternative to open surgery for elective AAA repair and has
proved short-term benefits compared with those of open
surgery.4,5 Inherent advantages of the endovascular tech-
nique in ruptured aneurysms are the possibility of avoiding
general anesthesia6 and the minimization of invasiveness in
hemodynamically unstable patients. Therefore translumi-
nal stent grafting has been advocated as an alternative to
open emergency surgery in patients with rAAA.7
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752In this study we will describe the clinical and morpho-
logic performance of bifurcated stent grafts in patients with
rAAA at midterm follow-up.
METHODS
Patients. All patients who underwent endovascular
repair of rAAA at our institution between June 1997 and
July 2003 were included in this study. On the basis of
computed tomographic–angiographic (CTA) morphol-
ogy, the availability of appropriate stent grafts, and success-
ful preoperative hemodynamic stabilization, 37 patients
were treated transluminally. Basically, morphologic inclu-
sion criteria corresponded to those accepted for elective
endovascular AAA repair. A minimal proximal neck length
of 15 mmwas requested throughout our experience. As for
neck diameters, the criteria changed over time as larger
devices became available. In the first 2 years, we had a
selection of Vanguard (Boston Scientific, Natick,Mass) and
Talent (Medtronic Vascular, Santa Rosa, Calif) devices on
the shelf. Gradually, we switched to Excluder (W.L. Gore,
Flagstaff, Ariz) and Zenith (Cook Inc, Bloomington, Ind)
devices. A hypotensive hemostatic approach with restricted
fluid resuscitation and limited administration of cat-
echolamines was applied.8 If hemodynamic parameters re-
mained stable, we proceeded to CTA and stent grafting.
During the same period of time, 52 patients with rAAA
underwent open surgical aneurysm repair. Patient demo-
graphics are summarized in Table I.
They all presented with comorbid conditions, which
significantly increased the operative risk. Median surgical
risk was 4, according to the American Society of Anesthe-
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temic disturbance considerably impairing daily activities
and presenting a constant threat to life.
Preinterventional imaging. In all patients a CTA was
obtained preinterventionally. In 15 patients the preinter-
ventional CTA was performed in a referring hospital. All
other patients received the preinterventional CTA on ad-
mission at our facility.
Because of 2 upgrades of the computed tomographic
(CT) scanner during the study, CT imaging was not uni-
form. Until the introduction of a multislice CT scanner in
our emergency unit, scanning was performed on a Single
Slice Spiral-CT (SOMATOM Plus 4; Siemens, Erlangen,
Germany). Since April 2000, CT imaging was done on a
4-Channel Multi-Detector Row CT (Volume Zoom; Sie-
mens), and after March 2003, CT imaging was done on a
16-Channel Multi-Detector Row-CT (Sensation 16; Sie-
mens). If needed, multiplanar 2-dimensional reconstruc-
tions were obtained for better evaluation of the aneurysmal
neck and to access the arterial anatomy. For follow-up
imaging, the same protocols were used.
For the purpose of our study, 2 experienced vascular
radiologists evaluated retrospectively in consensus the pre-
interventional and follow-up CT hard copies. Aneurysmal
morphology (type and extent), site and type of rupture, and
intraperitoneal and retroperitoneal fluid accumulations
were assessed. Thereby aneurysms were classified into types
A through E according to the method of Blum et al.10 The
site of rupture was located in the following areas: the upper,
middle, or lower third of the aneurysm or the left-posterior,
left-anterior, right-posterior, or right-anterior quadrant of
the aneurysmal transverse section. Furthermore, the exten-
sion of hematoma was grossly quantified with the number
of compartments involved: grade I, periaortic area; grade
II, periaortic plus retroperitoneal space; and grade III,
additional involvement of the mesentery. The presence or
absence of intraperitoneal hemorrhage, renal displacement,
and contrast agent extravasation was recorded.
Stent grafts and intervention. The stent grafts were
inserted in an operating room located next to the emer-
gency CT scanner equipped with a mobile C-arm fluoros-
copy (Siremobile; Siemens). After achievement of local or
general anesthesia, surgical exposure and arteriotomy of
either one or both common femoral arteries was performed
by using the same technique as for elective endovascular
repair. Transfemoral supraceliac aortic balloon occlusion
was performed if a patient became hemodynamically unsta-
ble during the procedure. The abovementioned different
commercially available stent grafts have been used. Distal or
proximal stent graft extensions were placed if necessary.
Postoperative management, imaging, and follow-up.
For postoperative surveillance, the patients were transferred
to the intensive care unit. CT scans were routinely per-
formed within 12 hours after completion of the procedure
to obtain a baseline postprocedural documentation of he-
matoma extension and because digital subtraction angiog-
raphy is not available in our emergency operating room.
Follow-upCT scans were performed at 3, 6, and 12monthsand annually. Again, 2 experienced radiologists retrospec-
tively assessed these examinations for size changes of aneu-
rysms, hematoma evolution, and postinterventional com-
plications, such as endoleaks, limb occlusions, stent graft
kinks, or migrations. The maximum aneurysmal diameter
was defined as the largest aneurysmal diameter in any
direction on the axial slices. If the aortic wall was blurred by
the surrounding hematoma on the initial scan, the maxi-
mum diameter was measured on a CT plane with obvious
wall calcifications outlining the aortic circumference and
compared on follow-up CT images at that same plane.
According to the time of appearance, endoleaks were clas-
sified as primary or secondary. Primary endoleaks are diag-
nosed within the 30-day perioperative period, whereas
secondary endoleaks appear in excluded aneurysms after
the 30-day perioperative period.11 Further classification
was done according to their cause: type I endoleaks result
from persistent leakage at the proximal (Ia) or distal (Ib)
ends of the graft; type II endoleaks are fed retrogradely
from lumbar arteries, the inferior mesentery artery, or other
collaterals; type III endoleaks originate from disconnected
grafts (IIIa), fabric tear, or graft desintegration (IIIb); and
type IV endoleaks are caused by the porosity of the graft
material.11
Secondary interventions were defined as any subse-
quent procedure, whether percutaneous or open surgical,
related to aneurysm repair or complications thereof.
Data regarding complications and eventual reinterven-
tions were extracted from patient charts.
Kaplan-Meier life tables were used for statistical analysis
of survival, conversion, endoleaks, secondary interventions,
and aneurysmal growth. If the standard error is greater than
10%, the data were not shown in the figures. Analysis for
aneurysmal growth factors was made with the Fisher exact
test. The analysis was made with SPSS 11.5 for Windows
(SPSS Inc, Chicago, Ill).
RESULTS
Preinterventional imaging. Our study group con-
sisted of 37 patients with ruptured infrarenal AAAs or
common iliac artery aneurysms (n  2). The mean aneu-
rysmal diameter was 77.2  21.3 mm. More than half
Table I. Patient demographics
Mean age (range), y 73.6 (53-90)
Sex (M/F), % 89/11
Median ASA class (range) 4 (3-5)
Mean duration of symptoms
(1 d/1 d), %
52/48
Mean systolic blood pressure in ED
(range), mm Hg
131 (55-195)
Patients with systolic blood pressure
100 mm Hg, %
21.6
Mean shock index (range), pulse
rate/mean systolic blood pressure
0.78 (0.39-1.7)
ASA, American Society of Anesthesiology (Keats, 1978, no. 26); ED,
emergency department.(51.4%) of all aneurysms were pure aortal, and 5.4% were
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to the classification of Blum et al.10 Thirty patients had an
identifiable aortic rupture site on CTA. In the remaining 5
patients with aortic or aortoiliac aneurysms, the site of
rupture could not be located on the CT scans. In both
patients with isolated iliac aneurysms, the exact rupture site
could not be located. Most ruptures (39.9%) were localized
in the middle third of the aneurysm or in the right anterior
quadrant of the transverse section (36.7%). Retroperitoneal
hematoma was graded as III in 19, II in 12, and I in 6
patients. Just less than half (43.2%) of all patients had
intraperitoneal fluid, corresponding to a free aneurysm
rupture. In 35.1% of all patients, extravasation of the con-
trast agent was observed on the preoperative CT. Renal
displacement caused by the hematoma was seen in 56.8% of
the patients.
Stent grafts and intervention. The stent grafts were
placed after achievement of local anesthesia in 28 patients
and after achievement of general anesthesia in 9 patients.
Arteriotomy was performed unilaterally in 25 and bilater-
ally in 12 cases. Transfemoral supraceliac aortic balloon
occlusion was performed temporarily in 3 patients who
became hemodynamically unstable during the procedure.
Because of presumed overstented renal arteries in one of
these patients, the balloon was left as a bridge to open
surgery. Thus in 36 (97%) of 37 patients, the stent graft was
implanted as intended.
In 2of 37patients, tube stent graftswere used (Vanguard,
Boston Scientific, n 1; Zenith, Cook, n 1), whereas 35 of
37 patients were treated with bifurcated stent grafts (Van-
guard, n  6; Excluder, Gore Inc, n  25; Talent, World
Medical-Medtronic, n  2; Zenith, n  2). In 23 patients
Fig 1. Kaplan-Meier curve of patient survival expressed as all-
cause mortality and aneurysm-related mortality.distal and in 6 patients proximal graft extensions were placed.The following additional procedures were performed at
stent graft placement in 8 patients: percutaneous translu-
minal angioplasty of a stenosed external iliac artery to give
way for endograft insertion (n  2), iliofemoral polytetra-
fluoroethylene grafting with proximal Palmaz stent fixation
for concomitant femoral artery aneurysm (n  1), ligation
of an overstented internal iliac artery (n  1), coil emboli-
zation of the superior and inferior gluteal artery (n  1) or
the internal iliac artery (n  1), stenting of a dissected
external iliac artery (n  1), aspiration of a deep femoral
artery embolus (n  1), and aneurysmal sac thrombin
injection (n  2).
Postinterventional imaging. During the postinter-
ventional period studied, 110 CT scans were performed
overall. On average, each patient was scanned 4 times
within a mean observation time of 24 months (97 weeks;
range, 1-252 weeks).
Sac shrinkage by 5mmormore was observed in 3.4%
3.3% of patients at 6 months, in 14.4% 6.7% of patients at
1 year, and in 30.8%  9.1% of patients at 2 years. Sac
enlargement occurred in 4.8%  4.7% of patients at 6
months, in 4.8% 4.7% of patients at 1 year, and in 15.3%
 10.8% of patients at 2 years. Preoperative CT findings,
like rupture site, contained rupture, or contrast extravasa-
tion, as well as postoperative CT findings, such as the
presence of endoleaks, showed no statistical correlation
with postoperative sac enlargement.
Early and late complications. Three patients had
postoperative abdominal compartment syndrome. One of
them required hematoma evacuation, whereas the other 2
were treated conservatively. Temporary hemofiltration for
acute renal failure was performed in 4 patients; one patient
of this group had compartment syndrome.
Three patients died perioperatively of the following
causes: sudden death, cholangitis with multiorgan failure,
and delayed free rupture of a common iliac artery, probably
because of dissection. In addition, one patient committed
suicide during the first postoperative month. Three patients
died over the follow-up period of nonaneurysm-related
causes: lymphoma, colon carcinoma, and bladder carci-
noma. No rerupture of the treated aneurysm was observed.
Overall survival was 89.1% 5% at 1 year, 83.9% 7% at 2
years, and 69.9%  11% at 4 years (Fig 1). The periopera-
tive mortality of the 52 patients undergoing open surgical
repair of rAAA was 35%.
One patient was immediately converted to open repair
because of renal overstenting. Late surgical conversion was
necessary in 3 patients (Table II). Stent graft migration was
the indication for conversion in 2 patients. In the third
patient, converted 6 weeks after stent grafting, a ruptured,
infrarenal, aortic, infectious pseudoaneurysm associated
with spondylodiscitis had been misdiagnosed as an “arte-
riosclerotic” rAAA. Overall conversion-free probability was
94.2%  4% at 1 year and 89.2%  6.1% at 2 and 4 years
(Fig 2). Endoleaks were responsible for 58.8% of all surgi-
cally or interventionally treated postoperative complica-
tions (Table III). Overall freedom from endoleak was 57%
 8.5% at 1 year and 48.8%  9% at 2 and 4 years (Fig 3).
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appearance are summarized in Table III. Survival without
secondary interventions was 64.7%  9% at 2 years and
55.4% 11% at 3 years. Forty-one percent of the secondary
interventions (7/17 secondary interventions) were within
1 month of the stent graft placement, most of them before
discharge of the patient. There were no complications
Table II. Complications requiring open or endovascular s
Complication Stent graft Emboliz
Endoleak
Type Ia
Type Ib 6
Type II 2
Type IIIa 2
Type IIIb
Migration 1
Limb/bypass occlusion
Abdominal compartment syndrome caused
by intra-abdominal hemorrhage
Infection
Total 9 2
Fig 2. Kaplan-Meier curve of conversion-free follow-up.
Table III. Endoleaks
Primary Secondary
Type Ia 0 0
Type Ib 6 3
Type II 6 5
Type IIIa 0 2
Type IIIb 0 0
Type IV 0 0associated with the secondary interventions.DISCUSSION
Of all patients with rAAA who are admitted alive to the
hospital, the operativemortality of emergency open surgery
has been estimated to be 41% for the year 2000.3,12 In this
situation the relatively new technique of endovascular stent
grafting is promising. The aneurysm can be approached
endoluminally by remote access through a femoral artery,
thus avoiding laparotomy. The closed abdominal wall, as
well as the unreleased retroperitoneal hematoma, impede
further blood loss because of the tamponade effect. The
endoluminal operation can be performed with local anes-
thesia.6 The abdominal wall tone and regulatory function
of the sympathetic system are not affected. These advan-
tages of endovascular repair appear obvious. Indeed, a
decrease in mortality, morbidity, and length of hospital stay
has been reported in nonrandomized single-center se-
ries.7,13-16 In our study 30-day mortality was 10.9%, which
ry
Bypass or
thrombectomy Surgical conversion Other Total events
6
2
2
2 3
2 2
1 1
1 1
2 3 1 17
Fig 3. Kaplan-Meier curve of freedom from endoleak over
follow-up.urge
ationis comparable with those results.
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stent grafting has its drawbacks. The limited durability of
stent grafts and the considerable rate of incompletely ex-
cluded aneurysmal sacs remain unsolved issues. Therefore
lifelong imaging follow-up has been advocated after elec-
tive endoluminal repair of aneurysms. As for rAAAs, the
morphologic evolution of the aneurysm has not yet been
studied. CTA is regarded as the standard diagnostic modal-
ity for surveillance of endovascularly treated AAAs because
it provides useful information on the evolution of the
aneurysm, the patency of the conduit, the presence of
endoleaks, and, to a limited extent, the stent graft in-
tegrity.17 By using the same CTA interval and protocol as
for nonruptured aortoiliac aneurysms, all consecutive pa-
tients with endovascular repair of ruptured aneurysms were
followed.
Endoleaks, occurring in up to a quarter of aneurysms
electively treated with self-expanding devices, might
present a persisting risk of rupture.18 At midterm follow-
up, freedom from endoleak was present in half of our
patients. All type I and III endoleaks were immediately
treated the same way as in nonruptured aneurysms, which is
by means of transluminal stent graft extension or interpo-
sition or, if not feasible, by means of surgical conversion.
There was no major complication at these secondary inter-
ventions.
Chronic (primary and secondary) type II endoleaks
were found in 30.5% of our patients. This is within the same
range as for nonruptured aneurysms with a variety of bifur-
cated commercial devices.19 At the very beginning of our
experience, 2 patients underwent transarterial coil emboli-
zation of type II endoleaks. Later, type II endoleaks were
no longer addressed. The fact that no aneurysm rerupture
occurred at midterm underlines the currently accepted
opinion that type II endoleaks are innocuous and need
treatment just if they are associated with aneurysmal
growth.
The cumulative risk of secondary aneurysm-related
procedures was 35% at 2 years and 44% at 3 years in our
series. These numbers seem to be more increased in com-
parison with those of nonruptured aneurysms. For in-
stance, by using the same definitions of secondary interven-
tions, a rate of 24% and 35%, respectively, has been reported
after elective transluminal AAA repair.19 The excessive rate
of secondary interventions in our series might be due to the
high rate of early postoperative interventions. The presence
of a suboptimal fluoroscopy unit in the emergency opera-
tion suite, worse visualization because of intra-abdominal
fluid, lack of the best-fitting stent graft on the shelf, and
intervention at night or on the weekend are some reasons
accounting for early additional interventions.
After the mean follow-up time, a reduction of aneurys-
mal diameter occurred in 30.8%, whereas it remained un-
changed in 53.9% and expanded in 15.3%. This stands in
conflict to a recently published series of 11 patients with
rAAAs treated with stent grafts who had a more marked
decrease of their aneurysmal diameter than those patients
treated for nonruptured aneurysms at the same institu-tion.20 One possible explanation might be the use of the
Excluder device in two thirds of the cases, which have
shown a delayed aneurysmal growth, even after a primary
decrease of the aneurysmal diameter.21
Our study is subject to some limitations. Because of a
certain selection bias, the perioperative mortality of endo-
vascularly treated rAAAs is not comparable with those after
open repair; however, this was beyond the purpose of this
study. Furthermore, the patients have been treated over a
period of more than 4½ years. In this time, CT technology
has evolved, and therefore scanner generations were not the
same for all patients. The assessment of the CT examina-
tions was done on hard copies because of the great number
of patients who had their first CT done in a referral hospital.
Therefore analysis of neck angulation and iliac kinking was
not possible, and the detection of small endoleaks is re-
stricted. The stent grafts used were from 4 different manu-
facturers, and the only feature they had in common was
their modular bifurcated design. In addition, stent graft
technology has progressed over the last years.
Our results indicate that the use of endoluminal devices
in rAAAs is able to convert the acute life-threatening situ-
ation to a controlled situation that results in good patient
survival at midterm follow-up, even if there is need for
subsequent procedures to prevent rerupture.
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